BLTPKC3&4

N/A

Report date: 2022/02/08 10:39:45
NME

Base Information

Drug NameBLTPKC3&4
Drug Alias NameBLTPKC4
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionGene silencingRNA interference
TargetsUpdating
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBenitec Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBenitec Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsCancer Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A